e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Diffuse parenchymal lung disease I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early
B. Jayaraman, F. Begum, K. Raj, H. Milburn (London, United Kingdom)
Source:
Annual Congress 2012 - Diffuse parenchymal lung disease I
Session:
Diffuse parenchymal lung disease I
Session type:
Thematic Poster Session
Number:
3614
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Jayaraman, F. Begum, K. Raj, H. Milburn (London, United Kingdom). Pulmonary graft-versus-host disease (GVHD) post- stem cell transplant (SCT) for haematological malignancies: Good response to treatment if diagnosed early. Eur Respir J 2012; 40: Suppl. 56, 3614
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003
Small airways function in allogeneic hematopoietic stem cell transplant recipients worsens over time and is correlated with change in chronic GVHD grade
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008
Lymphoma's and rejection after lung transplantation: balancing the immunosuppression
Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression
Year: 2005
Pulmonary mycobacterial infection in allogeneic hematopoietic stem cell transplanted (HSCT) patients: A study of 7 cases
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Respiratory infections in stem cell (SC) transplantation for Hodgkin's disease (HD)
Source: Eur Respir J 2002; 20: Suppl. 38, 353s
Year: 2002
Treatment options in chronic GVHD and CLAD post lung transplantation
Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities
Year: 2016
Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant
Source: Eur Respir J, 51 (5) 1702330; 10.1183/13993003.02330-2017
Year: 2018
Utility of bronchoscopy in hematopoietic stem cell transplant (HSCT) patients with pulmonary infiltrates: A prospective study.
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021
Pulmonary viral infection in hematologic patients with and without stemcell transplantation
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
Lung function prior to stem cell transplant as a predictor of infectious and pulmonary complications and survival in adults with haematologic malignancies
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Source: Eur Respir J 2004; 23: 440-445
Year: 2004
Is the FEV
1
the best spirometric value for early detection of airflow obstruction in chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation?
Source: Eur Respir J 2006; 28: Suppl. 50, 861s
Year: 2006
Forced oscillometry for early detection of bronchiolitis obliterans (BO) following hematogenous stem cell transplant (HSCT)
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept